Clinical features and diagnosis of sacroiliac joint region pain in 296 horses: 2004-2014

2015 ◽  
Vol 27 (12) ◽  
pp. 637-647 ◽  
Author(s):  
A. Barstow ◽  
S. Dyson
Keyword(s):  
Clinical Features ◽  
Sacroiliac Joint ◽  
Joint Region

Comparison of two ultrasound-guided injection techniques targeting the sacroiliac joint region in equine cadavers

2016 ◽  
Vol 29 (05) ◽  
pp. 386-393 ◽  
Author(s):  
Chiara Bergamino ◽  
Ruth Sanders ◽  
Ursula Fogarty ◽  
Antonella Puggioni ◽  
Clodagh Kearney ◽  
...  
Keyword(s):  
Sacroiliac Joint ◽  
Ultra Sound ◽  
Needle Guidance ◽  
Sacroiliac Joints ◽  
Ultrasound Guided ◽  
Joint Region ◽  
Median Distance ◽  
Iodinated Contrast ◽  
Before And After ◽  
Injection Techniques

Summary Objectives: To compare the accuracy and distribution of injectate for cranial (CR) and caudomedial (CM) ultrasound-guided injections of equine sacroiliac joints. Methods: Both sacroiliac joints from 10 lumbo sacropelvic specimens were injected using cranial parasagittal (CR; curved 18 gauge, 25 cm spinal needles) and caudomedial (CM; straight 18 gauge, 15 cm spinal needles) ultrasound-guided approaches. Injectate consisted of 4 ml iodinated contrast and 2 ml methylene blue. Computed tomo-graphical (CT) scans were performed before and after injections. Time for needle guidance and repositioning attempts were recorded. The CT sequences were analysed for accuracy and distribution of contrast. Results: Intra-articular contrast was detected in sacroiliac joints following 15/40 injections. The CR and CM approaches deposited injectate ≤ 2 cm from sacroiliac joint margins following 17/20 and 20/20 injections, respectively. Median distance of closest contrast to the sacroiliac joint was 0.4 cm (interquartile range [IQR]: 1.5 cm) for CR approaches and 0.6 cm (IQR: 0.95 cm) for CM approaches. Cranial injections resulted in injectate contacting lumbosacral intertrans-verse joints 15/20 times. Caudomedial injections were perivascular 16/20 times. Limitations: Safety and efficacy could not be established. Clinical relevance: Cranial and CM ultra-sound-guided injections targeting sacroiliac joints were very accurate for periarticular injection, but accuracy was poor for intra- articular injection. Injectate was frequently found in contact with interosseous sacroiliac ligaments, as well as neurovascular and synovial structures in close vicinity of sacroiliac joints.

Diagnosis and treatment of sacroiliac joint region pain in horses

UK-Vet Equine ◽  
2021 ◽  
Vol 5 (4) ◽  
pp. 150-157
Author(s):  
John David Stack ◽  
Jessica Harley
Keyword(s):  
Diagnostic Imaging ◽  
Diagnostic Test ◽  
Sacroiliac Joint ◽  
Joint Pain ◽  
Surgical Techniques ◽  
The Body ◽  
Anecdotal Evidence ◽  
Joint Region ◽  
Disease Treatment ◽  
Presumptive Diagnosis

The sacroiliac joint and pain deriving from this complex region remains poorly understood in horses, although our understanding grows as the body of literature grows. A deeper understanding can be derived from the richer body of literature in human sacroiliac joint pain as the disease processes and biomechanics appear similar in both species. A highly specific and sensitive diagnostic test for this condition does not exist, so equine clinicians have to make presumptive diagnosis based on presenting signs, findings of clinical examination, diagnostic imaging and the response to blocking of the sacroiliac joint region. Many horses with sacroiliac joint region pain have concurrent orthopaedic injury or disease. Treatment is largely based on fundamentals, anecdotal evidence and translation of non-surgical techniques used in humans. Treatment for other orthopaedic conditions can conflict with rehabilitation for sacroiliac joint region pain, necessitating compromise.

Quantification of fat in the posterior sacroiliac joint region applying a semi-automated segmentation method

2020 ◽  
Vol 191 ◽  
pp. 105386 ◽  
Author(s):  
Amélie Poilliot ◽  
Murray Tannock ◽  
Ming Zhang ◽  
Johann Zwirner ◽  
Niels Hammer
Keyword(s):  
Sacroiliac Joint ◽  
Automated Segmentation ◽  
Segmentation Method ◽  
Joint Region

scholarly journals Sciatica-like symptoms and the sacroiliac joint: clinical features and differential diagnosis

2013 ◽  
Vol 22 (7) ◽  
pp. 1657-1664 ◽  
Author(s):  
L. H. Visser ◽  
P. G. N. Nijssen ◽  
C. C. Tijssen ◽  
J. J. van Middendorp ◽  
J. Schieving
Keyword(s):  
Differential Diagnosis ◽  
Clinical Features ◽  
Sacroiliac Joint

scholarly journals Structural Lesion Progression of the Sacroiliac Joint and Clinical Features in axSpA During TNFi Reduction: A Retrospective Cohort Study

2021 ◽  
Vol 8 ◽  
Author(s):  
Qian Mo ◽  
Yuanji Dong ◽  
Cong Ye ◽  
Jixin Zhong ◽  
Shaozhe Cai ◽  
...  
Keyword(s):  
Ankylosing Spondylitis ◽  
Disease Activity ◽  
Treatment Response ◽  
Clinical Features ◽  
Sacroiliac Joint ◽  
Activity Index ◽  
Tumor Necrosis Factor Inhibitor ◽  
Average Dose ◽  
Structural Progression ◽  
The Status

Objective: In the clinic, some patients with axial spondyloarthritis (axSpA) have to reduce tumor necrosis factor inhibitor (TNFi) for various reasons. However, there are few studies about how to balance the relapse and TNFi reduction. Here we retrospectively analyzed the structural progression of the sacroiliac joint (SIJ) and clinical features in axSpA during TNFi reduction.Methods: A total of 108 patients with axSpA who followed up for 2 years and completed at least baseline, 12-month, and 24-month MRI scans of SIJ were divided into the tapering group (n = 63) and withdrawal group (n = 45) according to whether TNFi was stopped. We divided 2 years into five intervals, calculating the average dose quotient (DQ) for each of 540 intervals from 108 patients. By using generalized estimation equations with inverse probability of treatment weighting, we investigated the unbiased effects of average DQ on structural progression and treatment response.Results: The disease activity (such as Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Ankylosing Spondylitis Disease Activity Score (ASDAS)-CRP, and ASDAS-ESR) and relapse rate were lower in the tapering group at 12 and 24 months (p < 0.05). Δerosion (β = −0.0100, p = 0.00026) and Δthe Spondyloarthritis Research Consortium of Canada (SPARCC; β = −0.0959, p < 0.0001) were negatively correlated with average DQ. The average DQ 30 (74.8%, 80.0%) or 41.6 (76.5%, 83%) was best to discriminate the status of treatment response or the status of bone marrow edema, but considering operability, the average DQ 25 (78.0%, 63.3%) was also acceptable especially for patients with HLA-B27 negative and non-severe fat metaplasia.Conclusion: Complete TNFi withdrawal was not recommended. Our study provided a referable strategy (tapering then maintained the average DQ over 30 or even 25) for patients who need TNFi reduction. Higher dose usage of TNFi was associated with a slower erosion progression of SIJ.

scholarly journals Using Published Evidence to Guide the Examination of the Sacroiliac Joint Region

2001 ◽  
Vol 81 (5) ◽  
pp. 1135-1143 ◽  
Author(s):  
Janet K Freburger ◽  
Daniel L Riddle
Keyword(s):  
Sacroiliac Joint ◽  
Joint Region ◽  
Published Evidence
Sign in / Sign up

Export Citation Format

Share Document